Norrin is essential for cancer cell invasion (16) and serves as an LGR4 agonist in malignant cells, stimulating Wnt/β-catenin signaling to drive metastatic behavior through enhanced motility and tissue infiltration, thereby facilitating tumor advancement (55). Here, LGR4 is linked to neoplasm.